There is a high global demand for sensitive, portable, user-friendly, and cost-effective biosensors. In this work, we introduce a barometer-based biosensor for the detection of a broad range of targets. The device is operated by measuring the pressure change produced by oxygen (O 2 ) generation in a limited chamber using a portable barometer. The design employs core–shell Au@Pt nanoparticles (Au@PtNPs) as the bioassay probe to catalyze the decomposition of H 2 O 2 and the release of O 2 . As a proof of concept, we developed barometer-based immunosensors to detect carcinoembryonic antigen (CEA) and ractopamine (Rac). In addition, barometer-based aptasensors for sensitive detection of thrombin and mercury ion (Hg 2+ ) were also developed. In order to facilitate the analysis of results, we have developed smartphone software to calculate, save, and wirelessly trsnsmit the results. Linear detection ranges for detection of CEA, Rac, thrombin, and Hg 2+ were 0.025–1.6 ng/mL, 0.0625–4 ng/mL, 4–128 U/L, and 0.25–16 ng/mL, respectively. The detection limit of these four analytes is 0.021 ng/mL, 0.051 ng/mL, 2.4 U/L, and 0.22 ng/mL, respectively. Furthermore, the developed barometer-based biosensors exhibited high specificities for these four analytes. CEA in serum samples, Rac in urine samples, thrombin in serum samples, and Hg 2+ in river water samples were measured by the barometer-based biosensors. Obtained results of these targets from barometer-based biosensors were consistent with detection results from traditional methods, indicating that barometer-based biosensors are widely applicable.
No takes yet. Share an insight, caveat, or question.
Fu et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: